Clinical Trial Update: Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections [Phase 2]

View source ↗

Summary

Phase 2 trial update for meropenem-FL058 in complicated urinary tract infection and acute pyelonephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection
• Pyelonephritis

Drugs mentioned

• meropenem-FL058 (meropenem-FL058)

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Complicated Urinary Tract Infection, Acute Pyelonephritis | Phase 2 | Status: UNKNOWN